FSD Pharma Inc (HUGE)
0.332
-0.02
(-5.14%)
USD |
NASDAQ |
May 21, 16:00
0.35
+0.02
(+5.42%)
After-Hours: 20:00
FSD Pharma Price to Book Value: 1.162 for May 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 20, 2024 | 1.225 |
| May 17, 2024 | 1.116 |
| May 16, 2024 | 1.102 |
| May 15, 2024 | 1.139 |
| May 14, 2024 | 1.218 |
| May 13, 2024 | 1.278 |
| May 10, 2024 | 1.142 |
| May 09, 2024 | 1.180 |
| May 08, 2024 | 1.170 |
| May 07, 2024 | 1.223 |
| May 06, 2024 | 1.250 |
| May 03, 2024 | 1.243 |
| May 02, 2024 | 1.236 |
| May 01, 2024 | 1.262 |
| April 30, 2024 | 1.370 |
| April 29, 2024 | 1.472 |
| April 26, 2024 | 1.613 |
| April 25, 2024 | 1.589 |
| April 24, 2024 | 1.543 |
| April 23, 2024 | 1.560 |
| April 22, 2024 | 1.643 |
| April 19, 2024 | 1.568 |
| April 18, 2024 | 1.564 |
| April 17, 2024 | 1.549 |
| April 16, 2024 | 1.680 |
| Date | Value |
|---|---|
| April 15, 2024 | 1.757 |
| April 12, 2024 | 2.006 |
| April 11, 2024 | 2.070 |
| April 10, 2024 | 2.05 |
| April 09, 2024 | 2.051 |
| April 08, 2024 | 2.084 |
| April 05, 2024 | 2.116 |
| April 04, 2024 | 2.169 |
| April 03, 2024 | 2.217 |
| April 02, 2024 | 2.252 |
| April 01, 2024 | 2.324 |
| March 28, 2024 | 2.186 |
| March 27, 2024 | 2.112 |
| March 26, 2024 | 2.085 |
| March 25, 2024 | 1.994 |
| March 22, 2024 | 2.023 |
| March 21, 2024 | 2.097 |
| March 20, 2024 | 2.145 |
| March 19, 2024 | 2.172 |
| March 18, 2024 | 2.186 |
| March 15, 2024 | 2.127 |
| March 14, 2024 | 2.184 |
| March 13, 2024 | 2.246 |
| March 12, 2024 | 2.258 |
| March 11, 2024 | 2.324 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5735
Minimum
Mar 19 2020
6.720
Maximum
May 22 2019
1.578
Average
1.109
Median
Jan 10 2023
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.3996 |
| Aurinia Pharmaceuticals Inc | 2.115 |
| Edesa Biotech Inc | 3.384 |
| Lexaria Bioscience Corp | 5.770 |
| Xenon Pharmaceuticals Inc | 3.306 |
Price to Book Value Related Metrics
| Price | 0.332 |
| Earnings Yield | -78.31% |
| Market Cap | 13.98M |